GSA Capital Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-83,137
Closed -$435K 2052
2023
Q4
$435K Buy
83,137
+57,691
+227% +$302K 0.04% 889
2023
Q3
$401K Sell
25,446
-11,136
-30% -$175K 0.03% 926
2023
Q2
$711K Buy
36,582
+22,358
+157% +$435K 0.07% 520
2023
Q1
$404K Buy
+14,224
New +$404K 0.04% 850
2022
Q4
Sell
-23,137
Closed -$611K 1982
2022
Q3
$611K Buy
23,137
+6,081
+36% +$161K 0.08% 427
2022
Q2
$758K Buy
17,056
+636
+4% +$28.3K 0.11% 268
2022
Q1
$813K Buy
16,420
+11,657
+245% +$577K 0.11% 265
2021
Q4
$243K Buy
+4,763
New +$243K 0.03% 1082
2020
Q2
Sell
-6,142
Closed -$283K 1205
2020
Q1
$283K Sell
6,142
-4,225
-41% -$195K 0.07% 524
2019
Q4
$623K Sell
10,367
-1,475
-12% -$88.6K 0.07% 499
2019
Q3
$670K Sell
11,842
-7,164
-38% -$405K 0.09% 360
2019
Q2
$1.06M Sell
19,006
-4,046
-18% -$225K 0.12% 209
2019
Q1
$1.16M Sell
23,052
-9,348
-29% -$472K 0.12% 227
2018
Q4
$1.31M Buy
32,400
+8,500
+36% +$342K 0.15% 131
2018
Q3
$1.66M Buy
23,900
+18,600
+351% +$1.29M 0.09% 347
2018
Q2
$401K Sell
5,300
-2,500
-32% -$189K 0.02% 1262
2018
Q1
$411K Sell
7,800
-32,000
-80% -$1.69M 0.02% 1161
2017
Q4
$2.13M Buy
39,800
+23,900
+150% +$1.28M 0.13% 212
2017
Q3
$948K Sell
15,900
-12,600
-44% -$751K 0.06% 562
2017
Q2
$2.25M Sell
28,500
-3,500
-11% -$276K 0.15% 125
2017
Q1
$2.65M Buy
+32,000
New +$2.65M 0.14% 147
2016
Q2
Sell
-32,296
Closed -$1.31M 1960
2016
Q1
$1.31M Buy
32,296
+24,539
+316% +$994K 0.08% 403
2015
Q4
$688K Sell
7,757
-2,388
-24% -$212K 0.03% 956
2015
Q3
$751K Buy
+10,145
New +$751K 0.04% 862
2015
Q2
Sell
-21,500
Closed -$901K 2226
2015
Q1
$901K Buy
+21,500
New +$901K 0.04% 949